Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Nilan, Anandron, Anaconda
Nilutamide is a nonsteroidal antiandrogen used primarily in the treatment of advanced prostate cancer. It works by blocking the effects of androgens (male hormones like testosterone) on prostate cancer cells, thereby slowing their growth and spread. It is classified as a nonsteroidal antiandrogen and often used in combination with other hormonal therapies.
For the treatment of metastatic prostate cancer in combination with surgical castration.
Interstitial pneumonitis: Severe and potentially fatal interstitial pneumonitis has been reported with nilutamide. Monitor patients closely for pulmonary symptoms (e.g., dyspnea, cough, chest pain).
Outcome:
Increased bleeding risk
Mechanism:
Nilutamide inhibits warfarin metabolism.
Outcome:
Increased midazolam levels
Mechanism:
Nilutamide may inhibit midazolam metabolism.
Outcome:
Potential decreased nilutamide absorption
Mechanism:
Antacids may bind to nilutamide.
Most likely new formulation: Controlled-release nilutamide (Year: 2026, 30% confidence)
Based on current usage trends and clinical trial data, there is a low ( <5%) likelihood of any major regulatory changes to nilutamide's labeling in the next 2 years.
Antiandrogen, Antineoplastic
Anilide